Ubiquitination of HLA-DO by MARCH family E3 ligases

European Journal of Immunology

Volumn 43, Issue 5, 2013, Pages 1153-1161

  Jahnke, Martin ^a   Trowsdale, John ^a   Kelly, Adrian P ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

HLA DO; MHC antigen presentation; Ubiquitination

Indexed keywords

CD8 ANTIGEN; HLA DO ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MEMBRANE ASSOCIATED RING CH 1; MEMBRANE ASSOCIATED RING CH 8; MEMBRANE ASSOCIATED RING CH 9; POLYUBIQUITIN; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG;

ANTIGEN PRESENTATION; ARTICLE; CELLULAR DISTRIBUTION; CYTOPLASM; ENDOCYTOSIS; INTERNALIZATION; INTRACELLULAR MEMBRANE; LYSOSOME; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN MOTIF; PROTEIN PROCESSING; UBIQUITINATION;

AMINO ACID MOTIFS; B-LYMPHOCYTES; CELL LINE; CONSERVED SEQUENCE; CYTOPLASM; ENDOCYTOSIS; HEK293 CELLS; HLA-D ANTIGENS; HLA-DQ ANTIGENS; HUMANS; LYSINE; MEMBRANE PROTEINS; MOLECULAR SEQUENCE DATA; PLASMIDS; PROTEIN TRANSPORT; TRANSFECTION; UBIQUITIN; UBIQUITIN-PROTEIN LIGASES; UBIQUITINATION;

EID: 84876858943     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201243043     Document Type: Article

References (35)

1. Trowsdale, J. and Kelly, A., The human HLA class II alpha chain gene DZ alpha is distinct from genes in the DP, DQ and DR subregions. Embo. J. 1985. 4: 2231-2237.
2. Kelly, A. and Trowsdale, J., Complete nucleotide sequence of a functional HLA-DP beta gene and the region between the DP beta 1 and DP alpha 1 genes: comparison of the 5' ends of HLA class II genes. Nucleic Acids. Res. 1985. 13: 1607-1621.
3. Liljedahl, M., Kuwana, T., Fung-Leung, W. P., Jackson, M. R., Peterson, P. A. and Karlsson, L., HLA-DO is a lysosomal resident which requires association with HLA-DM for efficient intracellular transport. Embo. J. 1996. 15: 4817-4824.
4. Douek, D. C. and Altmann, D. M., HLA-DO is an intracellular class II molecule with distinctive thymic expression. Int. Immunol. 1997. 9: 355-364.
5. Hornell, T. M., Burster, T., Jahnsen, F. L., Pashine, A., Ochoa, M. T., Harding, J. J., Macaubas, C. et al., Human dendritic cell expression of HLA-DO is subset specific and regulated by maturation. J. Immunol. 2006. 176: 3536-3547.
6. Deshaies, F., Brunet, A., Diallo, D. A., Denzin, L. K., Samaan, A. and Thibodeau, J., A point mutation in the groove of HLA-DO allows egress from the endoplasmic reticulum independent of HLA-DM. Proc. Natl. Acad. Sci. USA 2005. 102: 6443-6448.
7. Chen, X., Laur, O., Kambayashi, T., Li, S., Bray, R. A., Weber, D. A., Karlsson, L. et al., Regulated expression of human histocompatibility leukocyte antigen (HLA)-DO during antigen-dependent and antigen-independent phases of B cell development. J. Exp. Med. 2002. 195: 1053-1062.
8. Cresswell, P., Assembly, transport, and function of MHC class II molecules. Annu. Rev. Immunol. 1994. 12: 259-293.
9. Denzin, L. K. and Cresswell, P., HLA-DM induces CLIP dissociation from MHC class II alpha beta dimers and facilitates peptide loading. Cell 1995. 82: 155-165.
10. Denzin, L. K., Sant'Angelo, D. B., Hammond, C., Surman, M. J. and Cresswell, P., Negative regulation by HLA-DO of MHC class II-restricted antigen processing. Science 1997. 278: 106-109.
11. Guce, A. I., Mortimer, S. E., Yoon, T., Painter, C. A., Jiang, W., Mellins, E. D. and Stern, L. J., HLA-DO acts as a substrate mimic to inhibit HLA-DM by a competitive mechanism. Nat. Struct. Mol. Biol. 2013. 20: 90-98.
12. Anders, A. K., Call, M. J., Schulze, M. S., Fowler, K. D., Schubert, D. A., Seth, N. P., Sundberg, E. J. et al., HLA-DM captures partially empty HLA-DR molecules for catalyzed removal of peptide. Nat. Immunol. 2011. 12: 54-61.
13. Doebele, R. C., Busch, R., Scott, H. M., Pashine, A. and Mellins, E. D., Determination of the HLA-DM interaction site on HLA-DR molecules. Immunity 2000. 13: 517-527.
14. Liljedahl, M., Winqvist, O., Surh, C. D., Wong, P., Ngo, K., Teyton, L., Peterson, P. A. et al., Altered antigen presentation in mice lacking H2-O. Immunity 1998. 8: 233-243.
15. van Lith, M., van Ham, M., Griekspoor, A., Tjin, E., Verwoerd, D., Calafat, J., Janssen, H. et al., Regulation of MHC class II antigen presentation by sorting of recycling HLA-DM/DO and class II within the multivesicular body. J. Immunol. 2001. 167: 884-892.
16. Xiu F, Côté M. H., Bourgeois-Daigneault M. C., Brunet A., Gauvreau M. É., Shaw A. and Thibodeau J., Cutting edge: HLA-DO impairs the incorporation of HLA-DM into exosomes. J. Immunol. 2011. 187: 1547-1551.
17. Draghi, N. A. and Denzin, L. K., H2-O, a MHC class II-like protein, sets a threshold for B-cell entry into germinal centers. Proc. Natl. Acad. Sci. USA 2010. 107: 16607-16612.
18. Shin, J. S., Ebersold, M., Pypaert, M., Delamarre, L., Hartley, A. and Mellman, I., Surface expression of MHC class II in dendritic cells is controlled by regulated ubiquitination. Nature 2006. 444: 115-118.
19. van Niel, G., Wubbolts, R., Ten Broeke, T., Buschow, S. I., Ossendorp, F. A., Melief, C. J., Raposo, G. et al., Dendritic cells regulate exposure of MHC class II at their plasma membrane by oligoubiquitination. Immunity 2006. 25: 885-894.
20. De Gassart, A., Camosseto, V., Thibodeau, J., Ceppi, M., Catalan, N., Pierre, P. and Gatti, E., MHC class II stabilization at the surface of human dendritic cells is the result of maturation-dependent MARCH I down-regulation. Proc. Natl. Acad. Sci. USA 2008. 105: 3491-3496.
21. Bourgeois-Daigneault, M. C. and Thibodeau, J., Autoregulation of MARCH1 expression by dimerization and autoubiquitination. J. Immunol. 2012. 188: 4959-4970.
22. Roucard, C., Thomas, C., Pasquier, M. A., Trowsdale, J., Sotto, J. J., Neefjes, J. and van Ham, M., In vivo and in vitro modulation of HLA-DM and HLA-DO is induced by B lymphocyte activation. J. Immunol. 2001. 167: 6849-6858.
23. Brunet, A., Samaan, A., Deshaies, F., Kindt, T. J. and Thibodeau, J., Functional characterization of a lysosomal sorting motif in the cytoplasmic tail of HLA-DO beta. J. Biol. Chem. 2000. 275: 37062-37071.
24. Hor, S., Ziv, T., Admon, A. and Lehner, P. J., Stable isotope labeling by amino acids in cell culture and differential plasma membrane proteome quantitation identify new substrates for the MARCH9 transmembrane E3 ligase. Mol. Cell. Proteomics 2009. 8: 1959-1971.
25. Lapaque, N., Jahnke, M., Trowsdale, J. and Kelly, A. P., The HLA-DR alpha chain is modified by polyubiquitination. J. Biol. Chem. 2009. 284: 7007-7016.
26. Jahnke, M., Trowsdale, J. and Kelly, A. P., Ubiquitination of human leukocyte antigen (HLA)-DM by different membrane-associated RING-CH (MARCH) protein family E3 ligases targets different endocytic pathways. J. Biol. Chem. 2012. 287: 7256-7264.
27. Glazier, K. S., Hake, S. B., Tobin, H. M., Chadburn, A., Schattner, E. J. and Denzin, L. K., Germinal center B cells regulate their capability to present antigen by modulation of HLA-DO. J. Exp. Med. 2002. 195: 1063-1069.
28. Welchman, R. L., Gordon, C. and Mayer, R. J., Ubiquitin and ubiquitin-like proteins as multifunctional signals. Nat. Rev. Mol. Cell Biol. 2005. 6: 599-609.
29. Karlsson, L., Surh, C. D., Sprent, J. and Peterson, P. A., A novel class II MHC molecule with unusual tissue distribution. Nature 1991. 351: 485-488.
30. Raiborg, C. and Stenmark, H., The ESCRT machinery in endosomal sorting of ubiquitylated membrane proteins. Nature 2009. 458: 445-452.
31. van Kerkhof, P., Putters, J. and Strous, G. J., The ubiquitin ligase SCF(betaTrCP) regulates the degradation of the growth hormone receptor. J. Biol. Chem. 2007. 282: 20475-20483.
32. Kropshofer, H., Vogt, A. B., Thery, C., Armandola, E. A., Li, B. C., Moldenhauer, G., Amigorena, S. et al., A role for HLA-DO as a co-chaperone of HLA-DM in peptide loading of MHC class II molecules. Embo. J. 1998. 17: 2971-2981.
33. Jahnke, M., Trowsdale, J. and Kelly, A. P., Structural requirements for recognition of major histocompatibility complex class II by membrane-associated RING-CH (MARCH) protein E3 ligases. J. Biol. Chem. 2012. 287: 28779-28789.
34. Ehrhardt, C., Schmolke, M., Matzke, A., Knoblauch, A., Will, C., Wixler, V. and Ludwig, S., Polyethylenimine, a cost-effective transfection reagent. Signal Transduction 2006. 6: 179-184.
35. Matsuki, Y., Ohmura-Hoshino, M., Goto, E., Aoki, M., Mito-Yoshida, M., Uematsu, M., Hasegawa, T. et al., Novel regulation of MHC class II function in B cells. Embo. J. 2007. 26: 846-854.